Discovery of [3-(4,5,7-trifluoro-benzothiazol-2-ylmethyl)-pyrrolo[2,3-b]pyridin-1-yl]acetic acids as highly potent and selective inhibitors of aldose reductase for treatment of chronic diabetic complications.

Abstract : Efforts to identify treatments for chronic diabetic complications have resulted in the discovery of a novel series of highly potent and selective [3-(4,5,7-trifluoro-benzothiazol-2-ylmethyl)-pyrrolo[2,3-b]pyridin-1-yl]acetic acid aldose reductase inhibitors. The lead candidate, [6-methyl-3-(4,5,7-trifluoro-benzothiazol-2-ylmethyl)-pyrrolo[2,3-b]pyridin-1-yl]acetic acid example 16, inhibits aldose reductase with an IC50 of 8 nM, while being inactive against aldehyde reductase (IC50>100 microM), a related enzyme involved in the detoxification of reactive aldehydes.
Type de document :
Article dans une revue
Bioorganic & Medicinal Chemistry Letters, Elsevier, 2009, 19 (7), pp.2006-8. 〈10.1016/j.bmcl.2009.02.037〉
Liste complète des métadonnées

http://www.hal.inserm.fr/inserm-00384538
Contributeur : Maité Peney <>
Soumis le : vendredi 15 mai 2009 - 13:50:16
Dernière modification le : jeudi 11 janvier 2018 - 06:17:43

Identifiants

Collections

Citation

Michael Van Zandt, Brian Doan, Diane Sawicki, Janet Sredy, Alberto Podjarny. Discovery of [3-(4,5,7-trifluoro-benzothiazol-2-ylmethyl)-pyrrolo[2,3-b]pyridin-1-yl]acetic acids as highly potent and selective inhibitors of aldose reductase for treatment of chronic diabetic complications.. Bioorganic & Medicinal Chemistry Letters, Elsevier, 2009, 19 (7), pp.2006-8. 〈10.1016/j.bmcl.2009.02.037〉. 〈inserm-00384538〉

Partager

Métriques

Consultations de la notice

58